Md. biotech firm to get European patent on leukemia drug candidate

A Maryland biotechnology company focused on cancer and sickle cell disease is set to receive a patent in Europe. The European Patent Office told GlycoMimetics Inc., which is based in Rockville, that it plans to grant a patent related to its drug candidate GMI-1271. The drug candidate is being evaluated in an ongoing phase 1 and …



Author: Baltimore Checkbook

Best in consumer news and deals in Baltimore, MD.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s